NASDAQ:GME

eBay Bounces Back; Focus Turns to GameStop Moves
·····

eBay Bounces Back; Focus Turns to GameStop Moves

eBay shares rose 1.6% to $112.13 Thursday after rejecting GameStop CEO Ryan Cohen’s $56 billion takeover bid. GameStop’s $125-a-share offer remains far above eBay’s trading price, reflecting investor doubts. eBay’s board called the bid “neither credible nor attractive” and cited financing concerns. GameStop disclosed direct ownership of 25,000 eBay shares and economic exposure to 29.1 million more through derivatives.
May 28, 2026

Stock Market Today

  • Telix Pharmaceuticals Advances Connected Oncology Platform with Positive Phase 1 Glioblastoma Trial and Prostate Cancer Collaborations
    May 28, 2026, 5:56 PM EDT. Telix Pharmaceuticals (ASX:TLX) announced full patient enrolment in its Phase 1 IPAX-2 trial for TLX101-Tx targeting glioblastoma, with no dose-limiting toxicities observed at highest doses. The firm also signed letters of intent to explore prostate cancer collaborations involving PSMA PET imaging, supporting its strategy to develop a connected oncology platform combining brain cancer therapy and prostate cancer imaging-based treatments. While encouraging for TLX101-Tx safety, the update does not alter focus on late-stage trials like IPAX BrIGHT or ProstACT GLOBAL. Telix faces risks including heavy reinvestment and an ongoing SEC subpoena linked to its prostate therapeutics segment. Analysts project Telix's revenue and earnings could reach A$1.2 billion and A$111 million by 2029, implying 22.7% annual growth and significant earnings expansion. Current stock price reflects potential for nearly 93% upside, though uncertainties remain.